Stonehage Fleming Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,150
Closed -$233K 151
2020
Q1
$233K Hold
1,150
0.01% 113
2019
Q4
$277K Hold
1,150
0.01% 117
2019
Q3
$223K Hold
1,150
0.01% 122
2019
Q2
$212K Hold
1,150
0.01% 116
2019
Q1
$218 Sell
1,150
-1,150
-50% -$220K 0.01% 123
2018
Q4
$448K Hold
2,300
0.03% 113
2018
Q3
$477K Sell
2,300
-1,150
-33% -$227K 0.03% 119
2018
Q2
$637K Buy
3,450
+1,150
+50% +$203K 0.03% 107
2018
Q1
$392K Sell
2,300
-1,450
-39% -$266K 0.03% 132
2017
Q4
$652K Sell
3,750
-1,150
-23% -$204K 0.04% 108
2017
Q3
$914K Buy
4,900
+750
+18% +$133K 0.04% 99
2017
Q2
$715K Sell
4,150
-7,200
-63% -$1.17M 0.04% 114
2017
Q1
$1.86M Sell
11,350
-3,350
-23% -$557K 0.12% 63
2016
Q4
$2.15M Buy
+14,700
New +$2.21M 0.13% 60

Other funds holding AMGN

Stonehage Fleming Financial Services's AMGN Position: Q2 2020 in Review

Stonehage Fleming Financial Services sold out of Amgen (AMGN) in Q2 2020, closing a stake of 1,150 shares — an estimated $233K sold.

Stonehage Fleming Financial Services first reported a position in AMGN in Q4 2016 and held it in 14 quarters. The position peaked at $2.15M in Q4 2016. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • Stonehage Fleming Financial Services reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 1,150 Amgen shares in Q2 2020, an estimated $233K.
  • Stonehage Fleming Financial Services first reported a position in Amgen in Q4 2016 and held it in 14 quarters.
  • Stonehage Fleming Financial Services's Amgen position peaked at $2.15M in Q4 2016.
  • 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2020, filed 13 Aug 2020.